LakeShore Biopharma Co Profit Margin

LakeShore Biopharma Co posts a profit margin of -75.61% as of March 2024. That is below the sector sector average of 19.69%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a profit margin near 19.69% is typical. LakeShore Biopharma Co's -75.61% is lower that level. That is roughly 484.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

LakeShore Biopharma Co's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -75.61% as of March 2024; use YoY and peer views to separate noise from signal.

Context for YS's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 19.69%), and (3) consistency with growth and profitability. This page covers the first two; LakeShore Biopharma Co's other metric pages and overview cover the third.